Frontiers in Oncology | Breast Cancer

Original Research

Published on 01 Nov 2024

The role of systemic immune-inflammation index in predicting pathological complete response of breast cancer after neoadjuvant therapy and the establishment of related predictive model

in Breast Cancer

Ziyue Zhang
Yixuan Zeng
Wenbo Liu

Frontiers in Oncology

doi 10.3389/fonc.2024.1437140

950 views

Review

Published on 31 Oct 2024

Mechanisms of endocrine resistance in hormone receptor-positive breast cancer

in Breast Cancer

Yuan Gao
Yang Yu
Mingqing Zhang
Wenjun Yu
Lihua Kang

Frontiers in Oncology

doi 10.3389/fonc.2024.1448687

1,517 views

Original Research

Published on 29 Oct 2024

Factors affecting lymphedema after neoadjuvant chemotherapy and axillary dissection in female breast cancer patients: a retrospective cohort study based on the Chinese population

in Breast Cancer

Jianqin Fu
Ruiliang Chen
Lijuan He
Liqun Bao
Zhaodi Lin
Weijing Jiang
Jie Zhang
Chuan Wang
Yanjuan Lin

Frontiers in Oncology

doi 10.3389/fonc.2024.1436748

859 views
1 citation

Systematic Review

Published on 28 Oct 2024

The effects of Tai Chi and Baduanjin on breast cancer patients: systematic review and meta-analysis of randomized controlled trials

in Breast Cancer

Yifang Chen
Yong Tang
Zhimiao Zhou

Frontiers in Oncology

doi 10.3389/fonc.2024.1434087

1,495 views

Original Research

Published on 25 Oct 2024

Clinical-radiomics nomogram based on the fat-suppressed T2 sequence for differentiating luminal and non-luminal breast cancer

in Breast Cancer

Yaxin Guo
Shunian Li
Jun Liao
Yuqi Guo
Yiyan Shang
Yunxia Wang
Qingxia Wu
Yaping Wu
Meiyun Wang

Frontiers in Oncology

doi 10.3389/fonc.2024.1451414

758 views

Review

Published on 25 Oct 2024

Obesity and lack of breastfeeding: a perfect storm to augment risk of breast cancer?

in Breast Cancer

Kate Ormiston
Anagh Kulkarni
Gautam Sarathy
Sara Alsammerai
Eswar Shankar
Sarmila Majumder
Kristin I. Stanford
Ramesh K. Ganju
Bhuvaneswari Ramaswamy

Frontiers in Oncology

doi 10.3389/fonc.2024.1432208

1,161 views

Original Research

Published on 23 Oct 2024

Triggered ferroptotic albumin-tocopherol nanocarriers for treating drug-resistant breast cancer

in Breast Cancer

Qianqian Gao
Tingting Liu
Li Sun
Yongliang Yao
Fang Li
Lingxiang Mao

Frontiers in Oncology

doi 10.3389/fonc.2024.1464909

1,049 views

Review

Published on 23 Oct 2024

Establishment of a clinical cancer genetics program for breast cancer in a resource-limited country; challenges and opportunities

in Breast Cancer

Hikmat Abdel-Razeq
Baha Sharaf
Faris Tamimi
Hira Bani Hani
Osama Alsmadi
Hanan Khalil
Mahmoud Abunasser
Sarah Edaily
Asem Mansour

Frontiers in Oncology

doi 10.3389/fonc.2024.1431985

5,098 views
1 citation

Case Report

Published on 21 Oct 2024

Hepatopulmonary syndrome associated with long-term use of ado-trastuzumab emtansine (T-DM1) for treatment of HER2-positive metastatic breast cancer - a case report and series

in Breast Cancer

Ciara C. O’Sullivan
Alexandra S. Higgins
Adham K. Alkurashi
Vaibhav Ahluwalia
Jodi L. Taraba
Paul M. McKie
Patrick S. Kamath
Vivek N. Iyer
Tufia C. Haddad

Frontiers in Oncology

doi 10.3389/fonc.2024.1434492

1,255 views

Original Research

Published on 17 Oct 2024

A risk prediction stratification for non-mass breast lesions, combining clinical characteristics and imaging features on ultrasound, mammography, and MRI

in Breast Cancer

YaMie Xie

Frontiers in Oncology

doi 10.3389/fonc.2024.1337265

747 views

Original Research

Published on 16 Oct 2024

HER2-low non-metastatic breast cancer in Qatar—a nationwide retrospective cohort study to evaluate the response to neoadjuvant chemotherapy: a real-world analysis

in Breast Cancer

Ahmed Kardousha
Wafaa Shehada
Ahmed Basha
Sahar Nasser
Mufid El Mistiri
Anas Hamad
Salha Bujassoum Al-Bader
Shereen Elazzazy

Frontiers in Oncology

doi 10.3389/fonc.2024.1398100

1,049 views

Editorial

Published on 16 Oct 2024

Editorial: Reviews in breast cancer: 2023

in Breast Cancer

Daniel P. Bezerra
Jie Ni
Sulma I. Mohammed
Maria Rosaria De Miglio

Frontiers in Oncology

doi 10.3389/fonc.2024.1488263

663 views

Systematic Review

Published on 14 Oct 2024

Research on therapeutic clinical trials including immunotherapy in triple-negative breast cancer: a bibliometric analysis

in Breast Cancer

Qi Xu
Xiaoyu Feng
Siyuan Qin
Yu Hong
Rui Cui
Jia Liang
Zhuya Xiao
Yuan Li

Frontiers in Oncology

doi 10.3389/fonc.2024.1423924

1,371 views

Review

Published on 10 Oct 2024

Targeted therapy approaches for epithelial-mesenchymal transition in triple negative breast cancer

in Breast Cancer

Mazharul Haque
Ritis K. Shyanti
Manoj K. Mishra

Frontiers in Oncology

doi 10.3389/fonc.2024.1431418

2,587 views
2 citations

Original Research

Published on 10 Oct 2024

Long-term exposure to BAY2416964 reduces proliferation, migration and recapitulates transcriptional changes induced by AHR loss in PyMT-induced mammary tumor cells

in Breast Cancer

Ninni Elise Olafsen
Siddhartha Das
Chiara Gorrini
Jason Matthews

Frontiers in Oncology

doi 10.3389/fonc.2024.1466658

1,387 views

Original Research

Published on 09 Oct 2024

Breast and axillary marking in the neoadjuvant setting: survey results from experts of the Brazilian society of mastology

in Breast Cancer

Henrique Lima Couto
Augusto Tufi Hassan
Dalton Ivan Steinmacher
Eduardo Carvalho Pessoa
Eduardo Camargo Millen
Felipe Zerwes
Francisco Pimentel Cavalcante
Giuliano Tosello
Guilherme Novita
Gustavo Machado Badan

Frontiers in Oncology

doi 10.3389/fonc.2024.1393417

984 views

Navigation group

Articles

The role of systemic immune-inflammation index in predicting pathological complete response of breast cancer after neoadjuvant therapy and the establishment of related predictive model

Mechanisms of endocrine resistance in hormone receptor-positive breast cancer

Factors affecting lymphedema after neoadjuvant chemotherapy and axillary dissection in female breast cancer patients: a retrospective cohort study based on the Chinese population

The effects of Tai Chi and Baduanjin on breast cancer patients: systematic review and meta-analysis of randomized controlled trials

Clinical-radiomics nomogram based on the fat-suppressed T2 sequence for differentiating luminal and non-luminal breast cancer

Obesity and lack of breastfeeding: a perfect storm to augment risk of breast cancer?

Triggered ferroptotic albumin-tocopherol nanocarriers for treating drug-resistant breast cancer

Establishment of a clinical cancer genetics program for breast cancer in a resource-limited country; challenges and opportunities

Hepatopulmonary syndrome associated with long-term use of ado-trastuzumab emtansine (T-DM1) for treatment of HER2-positive metastatic breast cancer - a case report and series

A risk prediction stratification for non-mass breast lesions, combining clinical characteristics and imaging features on ultrasound, mammography, and MRI

HER2-low non-metastatic breast cancer in Qatar—a nationwide retrospective cohort study to evaluate the response to neoadjuvant chemotherapy: a real-world analysis

Editorial: Reviews in breast cancer: 2023

Research on therapeutic clinical trials including immunotherapy in triple-negative breast cancer: a bibliometric analysis

Targeted therapy approaches for epithelial-mesenchymal transition in triple negative breast cancer

Long-term exposure to BAY2416964 reduces proliferation, migration and recapitulates transcriptional changes induced by AHR loss in PyMT-induced mammary tumor cells

Breast and axillary marking in the neoadjuvant setting: survey results from experts of the Brazilian society of mastology